China Pharma Holdings, Inc. (CPHI) reported a fiscal 2021 net loss of $3.4 million, compared to a loss of $2.9 million, prior year. Loss per share was $0.07, flat with prior year.
Revenue was $9.6 million, compared to $10.9 million, last year. The company said this was mainly due to the increase of existing product sales revenue in 2021 did not exceed the one-time foreign trade orders recognized in 2020, which was approximately $1.7 million.
As of December 31, 2021, the company had cash and cash equivalents of $4.9 million.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.